AVDL - Avadel Pharmaceuticals plc (AVDL) CEO Greg Divis on Q4 2020 Results - Earnings Call Transcript

Start Time: 08:30 End Time: 09:25 Avadel Pharmaceuticals plc (AVDL) Q4 2020 Earnings Conference Call March 09, 2021, 08:30 AM ET Company Participants Greg Divis - CEO Thomas McHugh - CFO Richard Kim - Chief Commercial Officer Jennifer Gudeman - VP of Medical and Clinical Affairs Conference Call Participants Eason Lee - SVB Leerink Thor Nagel - Stifel David Amsellem - Piper Jaffray Francois Brisebois - Oppenheimer David Sherman - Lifesci Capital Matthew Kaplan - Ladenburg Thalmann Robin Garner - Craig-Hallum Oren Livnat - H.C. Wainwright Presentation Operator Greetings. Welcome to the Avadel Pharmaceuticals Fourth Quarter and Full Year 2020 Earnings Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions]. Please note this conference is being recorded. I will now turn the conference over to your host, Tom McHugh. You may begin. Thomas McHugh Good morning and thank

For further details see:

Avadel Pharmaceuticals plc (AVDL) CEO Greg Divis on Q4 2020 Results - Earnings Call Transcript